Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Dec 06, 2021 7:41pm
96 Views
Post# 34204330

RE:RE:RE:Another New Job Posting: Paralegal, Corporate & Securities

RE:RE:RE:Another New Job Posting: Paralegal, Corporate & Securities

I hear you StockReddy, I am down big time...no denying. However, I will not sell at .95$ 

Everyone’s situation is different, I will hang on for a while longer…or go down with the ship.

 

I do not believe they will take this private, I could be wrong. And, contrary to what many are saying about letting the price drop and no news, what else can they possibly disclose? And, why would they hold a conference call? To reiterate that they are studying the MAD results once more?

 

My take is that after more in-depth analysis they figured that the return on Ryplazim was not worth the extra 10’s of millions (??) to bring it to market. This could also explain why Consonance jumped ship. They brought it across the finish line for the voucher and Kedrion was the only deal they had. I also believe that in order to receive the voucher the product has to be commercialized, hence Kedrion.

 

Finally, I think that it is just taking more time than anticipated to clean house and focus on the small molecules. My hope is that they post strong results with MAD and resume clinical trials for Fez….

 

Just my opinion of course and how I interpret this, some see the glass half-empty and others half-full.

 

Just don’t listen to all the noise on bullboards because it is just that a lot of unfounded craap…not facts.
 

StockReddy wrote:

Aldo, I was not listening to anybody and lost al lot, hard to digest but true. I think playing casino is better then playing with LMNL. Everyone in my friends list made this year a lot of money in stocks and I only lost due to LMNL. 

 



<< Previous
Bullboard Posts
Next >>